PepGen (PEPG)

• Market cap: $35.6M
• 1 day: -13.49%
• 5 days: -23.78%
• 1 month: -52.19%
• 3 months: -70.38%
• 6 months: -88.28%
• Year to date: -71.09%
• 1 year: -90.60%
• 5 years: -91.54%
• 10 years: -91.54%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1.17% less ownership

Funds ownership: 77.82% [Q3] → 76.65% (-1.17%) [Q4]

3% less funds holding

Funds holding: 62 [Q3] → 60 (-2) [Q4]

56% less capital invested

Capital invested by funds: $217M [Q3] → $94.7M (-$122M) [Q4]

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $57K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $16 1,368% upside
• Avg. target: $16 1,368% upside
• High target: $16 1,368% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Andrew Fein 28% 1-year accuracy 99 / 359 met price target

1,368% upside $16

Buy Reiterated

24 Feb 2025